Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Comprehensive Clinical and Molecular Characterization Reveals Rara As the Most Frequent Torque Teno Mini Virus Insertion Site and Defines a Distinct Ttmv::Rara Driven APL-like Leukemia Subtype

Blood (2024) 144 (Supplement 1): 1547.

https://doi.org/10.1182/blood-2024-202323

Published: 2024

Journal Articles

Single-Cell RNA Sequencing Uncovers Distinct Molecular Characteristics and Immune Suppression Profiling of AML with Retinoic Acid Receptor γ Rearrangement

Qing-Yu Xu, Shu Sun, Yebo Peng, Yingying Huo, Ting Shi, Wen Gao, Hong-Hu Zhu

Blood (2024) 144 (Supplement 1): 5724.

https://doi.org/10.1182/blood-2024-204959

Published: 2024

Journal Articles

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Blood (2024) 144 (14): 1471–1485.

https://doi.org/10.1182/blood.2024023883

Published: 2024

Includes: Supplemental data

Journal Articles

Mitoxantrone Hydrochloride Liposome, Bortezomib, and Dexamethasone- Based Regimen in Multiple Myeloma Patients with Extramedullary Plasmacytoma: A Pilot Study

Yuan Jian, Nian Liu, Yan-Ru Zhang, Wen Gao, Wen-Ming Chen, Hong-Hu Zhu, Yin Wu

Blood (2023) 142 (Supplement 1): 6650.

https://doi.org/10.1182/blood-2023-188304

Published: 2023

Journal Articles

APL: Nemo finds its sea anemone

Qian-Fei Wang, Hong-Hu Zhu

Blood (2022) 140 (22): 2311–2312.

https://doi.org/10.1182/blood.2022018020

Published: 2022

Journal Articles

Venetoclax Plus "2 + 5" Modified Intensive Chemotherapy with Daunorubicin and Cytarabine in Fit Elderly Patients with Untreated De Novo Acute Myeloid Leukemia: A Single-Center Retrospective Analysis

Huafeng Wang, Yiyi Yao, Liping Mao, Yinjun Lou, Yanling Ren, Xingnong Ye, Min Yang, Liya Ma, Yi Zhang, Yile Zhou, Xin Huang, Yungui Wang, Huan Xu, Hongyan Tong, Hong-hu Zhu, Jie Jin

Blood (2022) 140 (Supplement 1): 3350–3351.

https://doi.org/10.1182/blood-2022-165738

Published: 2022

Journal Articles

Targeting HDAC3 to Overcome the Resistance to ATRA or Arsenic in Acute Promyelocytic Leukemia through Ubiquitination and Degradation of PML-RARα

Bo Dai, Feng Wang, Ying Wang, Jiayan Zhu, Yunxuan Li, Tingting Zhang, Luyao Zhao, Li-Ling Wang, Wenhui GAO, Junmin Li, Aibin Liang, Hong-hu Zhu, Ke Li, Jiong Hu

Blood (2022) 140 (Supplement 1): 5924–5925.

https://doi.org/10.1182/blood-2022-156735

Published: 2022

Journal Articles

The ZR2-Minichop Study：Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Jianai Sun, Yi Xu, Min Yang, Huafeng Wang, Wenjuan Yu, Liangshun You, Haitao Meng, Chunmei Yang, Xinping Zhou, Li Li, De Zhou, Xiujing Ye, Hong-hu Zhu, Hongyan Tong, Jie Jin, Wanzhuo Xie

Blood (2022) 140 (Supplement 1): 3756.

https://doi.org/10.1182/blood-2022-158723

Published: 2022

Journal Articles

Realgar Indigo Formula Plus ATRA As Postremission Treatment in an Rral and Chemo-Free Model for High-Risk Acute Promyelocytic Leukemia Patients: A Prospective, Multicenter, Phase II Study

Hong-hu Zhu, Ya-fang Ma, Suning Chen, Ying Lu, Jiang Huang, Huai-Yu Wang, Xiaohua Xu, Bing-Shou Xie, Yinjun Lou, Jie Jin

Blood (2021) 138 (Supplement 1): 873.

https://doi.org/10.1182/blood-2021-149141

Published: 2021

Journal Articles

Venetoclax Combined with Daunorubicin and Cytarabine (DAV) As Induction Therapy in De Novo Young Adult Acute Myeloid Leukemia

Huafeng Wang, Liping Mao, Wanzhuo Xie, Hongyan Tong, Min Yang, Gaixiang Xu, Xiujin Ye, Ying Lu, Juying Wei, Wenyuan Mai, De Zhou, Jie Jin, Hong-Hu Zhu

Blood (2021) 138 (Supplement 1): 2334.

https://doi.org/10.1182/blood-2021-153257

Published: 2021

Journal Articles

Ruxolitinib Combined with Dexamethasone in Adult Patients with Secondary HLH：a Single-Centre Pilot Trial

De Zhou, Xianbo Huang, Mixue Xie, Hong-Hu Zhu, Jie Jin, Xiujing Ye

Blood (2021) 138 (Supplement 1): 198.

https://doi.org/10.1182/blood-2021-152921

Published: 2021

Journal Articles

Venetoclax-Ponatinib for T315I/Compound-Mutated Ph+Acute Lymphoblastic Leukemia

Huafeng Wang, Jiejing Qian, Chang Yang, Yi Zhang, Yungui Wang, Ting Shi, Yongxian HU, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura, Jie Jin, Hong-Hu Zhu

Blood (2021) 138 (Supplement 1): 3395.

https://doi.org/10.1182/blood-2021-152836

Published: 2021

Journal Articles

Interim Results of a Phase II Study of Dasatinib and Prednisone As an Oral, Chemo-Free Induction and Consolidation Regimen for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Mixue Xie, Ying Lu, Guifang Ouyang, Liming Zhang, Huixian Hu, Ting Shi, Xueying Li, Xiujing Ye, Jie Jin, Hong-Hu Zhu

Blood (2021) 138 (Supplement 1): 4402.

https://doi.org/10.1182/blood-2021-152554

Published: 2021

Journal Articles

Clinical Correlation of a Precision Medicine Test with Treatment Outcome in Acute Myeloid Leukemia Patients

Hong-Hu Zhu, MD, Min Ji, MD, Chunyan Ji, MD, Chongwu Wang, Yaqiong Ge, Xiaoping Zhou, Julian Gorrochategui, Daniel Primo, PhD, Joan Ballesteros, PhD, Li Li, MD, Joaquin Martinez-López

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-140252

Published: 2020

Journal Articles

The simpler, the better: oral arsenic for acute promyelocytic leukemia

Hong-Hu Zhu, Jiong Hu, Francesco Lo-Coco, Jie Jin

Blood (2019) 134 (7): 597–605.

https://doi.org/10.1182/blood.2019000760

Published: 2019

Includes: Supplemental data

Journal Articles

PML Mutation in PML-Rarα Alters PML Nuclear Body Organization and Induces ATRA Resistance in Acute Promyelocytic Leukemia

Hong-Hu Zhu, MD, Congying Wu, Yujie Sun, Jiong Hu, MD

Blood (2018) 132 (Supplement 1): 3923.

https://doi.org/10.1182/blood-2018-99-118310

Published: 2018

Journal Articles

Oral arsenic and all- trans retinoic acid for high-risk acute promyelocytic leukemia

Hong-Hu Zhu, Yan-Rong Liu, Jin-Song Jia, Ya-Zhen Qin, Xiao-Su Zhao, Yue-Yun Lai

Blood (2018) 131 (26): 2987–2989.

https://doi.org/10.1182/blood-2018-02-834051

Published: 2018

Includes: Supplemental data

Journal Articles

Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in MDS-EB and AML-MRC

Jing Liu, MD PhD, Jinsong Jia, MD, Li-Zhong Gong, MD, Shen-ye Lu, MD, Hong-Hu Zhu, MD, Xiao-Jun Huang, MD, Hao Jiang, MD

Blood (2017) 130 (Supplement 1): 2980.

https://doi.org/10.1182/blood.V130.Suppl_1.2980.2980

Published: 2017

Journal Articles

The Real World of Arsenic Uses in Chinese with Acute Promyelocytic Leukemia: A Cross-Sectional Survey

Hong-Hu Zhu, MD, Feng-Mei Zheng, Xiao-Jun Huang

Blood (2016) 128 (22): 5955.

https://doi.org/10.1182/blood.V128.22.5955.5955

Published: 2016

Journal Articles

The Initial Level of MLL-PTD Affects the Prognosis of Patients with Acute Myeloid Leukemia

Jun Kong, MD, Hao Jiang, MD, Yazhen Qin, Xiaosu Zhao, Dr., Hong-Hu Zhu, MD, Jinsong Jia, MD, Qian Jiang, MD, Jing Wang, MD, Ting Zhao, Xiao-Jun Huang

Blood (2016) 128 (22): 5241.

https://doi.org/10.1182/blood.V128.22.5241.5241

Published: 2016

NARROW

Comprehensive Clinical and Molecular Characterization Reveals Rara As the Most Frequent Torque Teno Mini Virus Insertion Site and Defines a Distinct Ttmv::Rara Driven APL-like Leukemia Subtype

Single-Cell RNA Sequencing Uncovers Distinct Molecular Characteristics and Immune Suppression Profiling of AML with Retinoic Acid Receptor γ Rearrangement

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Mitoxantrone Hydrochloride Liposome, Bortezomib, and Dexamethasone- Based Regimen in Multiple Myeloma Patients with Extramedullary Plasmacytoma: A Pilot Study

APL: Nemo finds its sea anemone

Venetoclax Plus "2 + 5" Modified Intensive Chemotherapy with Daunorubicin and Cytarabine in Fit Elderly Patients with Untreated De Novo Acute Myeloid Leukemia: A Single-Center Retrospective Analysis

Targeting HDAC3 to Overcome the Resistance to ATRA or Arsenic in Acute Promyelocytic Leukemia through Ubiquitination and Degradation of PML-RARα

The ZR2-Minichop Study：Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Realgar Indigo Formula Plus ATRA As Postremission Treatment in an Rral and Chemo-Free Model for High-Risk Acute Promyelocytic Leukemia Patients: A Prospective, Multicenter, Phase II Study

Venetoclax Combined with Daunorubicin and Cytarabine (DAV) As Induction Therapy in De Novo Young Adult Acute Myeloid Leukemia

Ruxolitinib Combined with Dexamethasone in Adult Patients with Secondary HLH：a Single-Centre Pilot Trial

Venetoclax-Ponatinib for T315I/Compound-Mutated Ph+Acute Lymphoblastic Leukemia

Interim Results of a Phase II Study of Dasatinib and Prednisone As an Oral, Chemo-Free Induction and Consolidation Regimen for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Clinical Correlation of a Precision Medicine Test with Treatment Outcome in Acute Myeloid Leukemia Patients

The simpler, the better: oral arsenic for acute promyelocytic leukemia

PML Mutation in PML-Rarα Alters PML Nuclear Body Organization and Induces ATRA Resistance in Acute Promyelocytic Leukemia

Oral arsenic and all- trans retinoic acid for high-risk acute promyelocytic leukemia

Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in MDS-EB and AML-MRC

The Real World of Arsenic Uses in Chinese with Acute Promyelocytic Leukemia: A Cross-Sectional Survey

The Initial Level of MLL-PTD Affects the Prognosis of Patients with Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only